Maintenance agreement
Active Awarded Last action
- Contract number
- 75N91023F00032
- Awardee
-
Becton, Dickinson And Company UEI MM5ZHL8SRFY5 Part of Becton, Dickinson And Co
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $123,873
Award facts
- Contract value 80% obligated
-
- $123,872.64 Current, with exercised options
- $154,840.80 Potential, with all options
- Completion date 75% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $30,968 | |
| Exercise an Option | $30,968 | |
| Exercise an Option | $30,968 | |
| Original award | $30,968 |
About this award
Becton, Dickinson and Company, through its BD Biosciences division, was awarded a delivery order maintenance agreement by the National Cancer Institute valued at $154,840.80 under the Multiple Award Schedule on February 1, 2023. This firm fixed-price contract, with an ultimate completion date of January 31, 2028, provides maintenance services for specialized laboratory instrumentation at the National Cancer Institute's Bethesda, Maryland facility. The award is part of BD's broader portfolio of federal contracts supporting the National Institutes of Health and its component institutes, including a single-award Indefinite Delivery Contract with the NIH Clinical Center valued at $1.25 million for flow cytometry instrumentation, reagent kits, quality control materials, and supplies. No small business set-aside was utilized for this procurement, reflecting BD's established position as a large, qualified federal contractor.
This maintenance agreement supports the National Cancer Institute's biomedical research mission by ensuring operational continuity of BD's specialized laboratory equipment, which includes flow cytometry systems essential to cancer research and diagnostic applications. BD Biosciences provides comprehensive maintenance services across federal healthcare and research agencies, including preventive maintenance, corrective repairs, software support, and technical assistance. The contract operates within the broader context of the company's substantial federal presence, with multiple indefinite delivery vehicles across the Department of Veterans Affairs, Defense Health Agency, and other federal agencies totaling over $7 million in aggregate ceiling value, positioning BD as a critical supplier of advanced laboratory instrumentation to the federal government.
Quick answers
Who was awarded contract 75N91023F00032?
75N91023F00032 was awarded to Becton, Dickinson And Company by National Cancer Institute (National Institutes of Health) on February 1, 2023.
How much is contract 75N91023F00032 worth?
The government has obligated $123,873 on 75N91023F00032. Its potential value, with all options, is $154,841.
Is contract 75N91023F00032 an order under another contract?
Yes. 75N91023F00032 is a delivery order under GS07F195DA, a federal supply schedule, on Multiple Award Schedule (MAS).
Was contract 75N91023F00032 competed?
The extent of competition for 75N91023F00032 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award